germany
germany · page 4
- Industry Trends
Why is No One Talking About Germany’s Oversupply Problem?
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
- Clinical Research
How Cannabis Interacts with Pain, Sleep & Anxiety
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and a growing demand for alternatives to conventional pharmaceuticals.
- International Regulation
Drug War 2.0 Puts International Cannabis Reform at Risk
The United States is intensifying its controversial overseas ‘war on drugs’ even as a prolonged government shutdown paralyses domestic policy, a combination that threatens to reshape the outlook for cannabis reform and regulation This morning, news broke that the US military had carried out another series of airstrikes on alleged drug traffickers in the Eastern…
- UK & Europe
Cannabis Researchers Call for Implementation of Second Pillar of the KCanG
When Germany introduced the Recreational Cannabis Act (KCanG), it not only legalised home cultivation and consumption for adults but also laid the groundwork for scientifically monitored pilot projects allowing the legal sale of cannabis at authorised distribution points.
- Pharmaceutical
Europe’s First Ever ‘Whole Plant’ Cannabis Medicine Could be Available by 2026 in Major Step Forward for Non-Opioid Pain Treatment
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval.
- UK & Europe
‘No One Expected the Surge’: Grunhorn on How Telemedicine Took German Medical Cannabis by Storm
Since April 2024, Germany has been firmly cemented at the centre of the global cannabis conversation, and for good reason.
- Investment & Finance
UK Clinic Releaf Expands into Germany, Aiming for Top Spot Within Six Months
UK clinic Releaf expands into Germany, leveraging its digital health ecosystem to capture market share in Europe’s fast-growing medical cannabis sector.
- International Regulation
Inside Australia’s Medical Cannabis Boom: Prescriptions, Products & Patients
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow nearly tenfold in just three years, according to new official data.
- Medical Cannabis
Import Approvals Paused as Germany Hits 2025 Medical Cannabis Limit
The Federal Institute for Drugs and Medical Devices (BfArM) has announced that Germany’s estimated annual demand for medical cannabis in 2025 has already been reached, leading to a temporary suspension of new import licences.
- UK & Europe
What Does the First Official Data on Germany’s Cannabis Reforms Show?
Germany’s booming cannabis market, which Prohibition Partners now estimates to be worth around €670m, is entering uncertain and potentially treacherous territory.
- Legal Analysis
European Law Could Block German Health Ministry’s Plan to Ban Telemedicine for Cannabis Prescriptions
Telemedicine and access to medical cannabis via online platforms have become a central issue in Germany’s cannabis sector, drawing scrutiny from policymakers and healthcare professionals.
- Cultivation
Licences Without Land: Cannabis Social Clubs Effectively Blocked in Bavaria
The legalisation of cannabis in Germany on 1 April 2024 was intended to mark a paradigm shift in drug policy.
